The Federal Trade Commission has reached a landmark settlement with Express Scripts, addressing allegations that the pharmacy benefit manager inflated drug prices, including for insulin, to boost ...
Preview this article 1 min The dispute centers on prescription drug claims between 2020 and 2022. Charter alleges the ...
Jefferson County’s long-running opioid fight with pharmacy benefit managers Express Scripts and Optum Rx now has a firm trial ...
SECAUCUS, N.J., March 12, 2026 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced that its board of directors has ...
The Federal Trade Commission’s Feb.4 consent order with Express Scripts represents the most consequential structural overhaul of the pharmacy benefit manager industry to date. Policymakers and ...
CHARLESTON, W.Va. — The West Virginia Independent Pharmacy Association is praising a state order and fine issued Monday against Express Scripts (ESI) for violations of laws designed to protect local ...
On February 4, 2026, the Federal Trade Commission (FTC) proposed to settle its enforcement action against leading pharmacy benefit manager (PBM) Express Scripts, going beyond the insulin products that ...
A Chicago plumbers’ union is accusing Express Scripts Inc. of giving certain drugmakers preferential patient access in exchange for billions of dollars in rebates it withheld from the union health ...
On February 4, 2026, Express Scripts agreed to a settlement with the Federal Trade Commission (FTC) in the agency’s administrative case against the nation’s three largest pharmacy benefit managers ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Hamilton County joins a wave of ...
The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results